Creative Planning
PSTV

Creative Planning’s Plus Therapeutics PSTV Stock Holding History

Creative Planning’s Portfolio PSTV Stock Details PSTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-89
Closed -$9.73K – 2789
2023
Q1 		$9.73K Hold
89
– – ﹤0.01% 2466
2022
Q4 		$10.6K Hold
89
– – ﹤0.01% 2351
2022
Q3 		$15K Hold
89
– – ﹤0.01% 2200
2022
Q2 		$18K Buy
89
+33
+59% +$8.24K ﹤0.01% 2154
2022
Q1 		$21K Hold
56
– – ﹤0.01% 2133
2021
Q4 		$22K Buy
56
+7
+14% +$4.03K ﹤0.01% 2037
2021
Q3 		$35K Hold
49
– – ﹤0.01% 2023
2021
Q2 		$47K Buy
49
+5
+11% +$4.52K ﹤0.01% 1940
2021
Q1 		$39K Buy
44
+7
+19% +$7.1K ﹤0.01% 2381
2020
Q4 		$28K Buy
+37
New +$31.6K ﹤0.01% 2156
2018
Q2 		– Hold
0
– -$22K – 2153
2018
Q1 		– Hold
0
– – – 1880
2017
Q4 		– Hold
0
– – – 1848
2017
Q3 		– Hold
0
– – – 1816
2017
Q2 		– Hold
0
– – – 2095
2017
Q1 		– Hold
0
– – – 1816
2016
Q4 		– Hold
0
– – – 1751
2016
Q3 		– Hold
0
– – – 1545
2016
Q2 		– Hold
0
– – – 4041
2016
Q1 		– Hold
0
– – – 3828
2015
Q4 		– Hold
0
– – – 4054
2015
Q3 		– Hold
0
– – – 3725
2015
Q2 		– Hold
0
– – – 1096
2015
Q1 		– Hold
0
– – – 2982
2014
Q4 		– Hold
0
– – – 3413

Other funds holding PSTV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Creative Planning's PSTV Position: Q2 2023 in Review

Creative Planning sold out of Plus Therapeutics (PSTV) in Q2 2023, closing a stake of 89 shares — an estimated $9.73K sold.

Creative Planning first reported a position in PSTV in Q4 2020 and held it in 10 quarters. The position peaked at $47K in Q2 2021. 6 funds tracked by Wall St. Rank hold PSTV as of Q2 2023.

  • Creative Planning reported no remaining Plus Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Creative Planning sold 89 Plus Therapeutics shares in Q2 2023, an estimated $9.73K.
  • Creative Planning first reported a position in Plus Therapeutics in Q4 2020 and held it in 10 quarters.
  • Creative Planning's Plus Therapeutics position peaked at $47K in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Plus Therapeutics as of Q2 2023.

Based on Creative Planning's 13F filing for Q2 2023, filed 21 Jul 2023.